122 related articles for article (PubMed ID: 6446456)
1. Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin.
Maeda H; Takeshita J; Yamashita A
Eur J Cancer (1965); 1980 May; 16(5):723-31. PubMed ID: 6446456
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans.
Comis RL; Griffin TW; Raso V; Ginsberg SJ
Cancer Res; 1979 Mar; 39(3):757-61. PubMed ID: 154969
[No Abstract] [Full Text] [Related]
3. Pharmacokinetic analysis of neocarzinostatin in normal and tumor-bearing rodents.
Lowenthal IS; Parker LM; Greenblatt DJ; Brown BL; Samy TS
Cancer Res; 1979 May; 39(5):1547-51. PubMed ID: 154972
[No Abstract] [Full Text] [Related]
4. In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
Takeshita J; Maeda H; Kanamaru R
Gan; 1982 Apr; 73(2):278-84. PubMed ID: 6214446
[TBL] [Abstract][Full Text] [Related]
5. [Study on the localization of neocarzinostatin in various tissues by enzyme-labeled antibody method--with special reference to the distribution into oral region (author's transl)].
Shimada T
Kokubyo Gakkai Zasshi; 1981 Mar; 48(1):1-12. PubMed ID: 6454734
[No Abstract] [Full Text] [Related]
6. Degradation of neocarzinostatin by blood sera in vitro and its inhibition by diisopropyl fluorophosphate and n-ethylmaleimide.
Maeda H; Takeshita J
Gan; 1975 Oct; 66(5):523-7. PubMed ID: 130275
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.
Maeda H; Sakamoto S; Ogata J
Antimicrob Agents Chemother; 1977 Jun; 11(6):941-5. PubMed ID: 141906
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the stability of antitumor protein, neocarzinostatin. II. Stability of injection of neocarzinostatin (author's transl)].
Kono M; Ishii F; Haneda I; Koyama Y; Kikuchi M
Jpn J Antibiot; 1974 Dec; 27(6):715-24. PubMed ID: 4282495
[No Abstract] [Full Text] [Related]
9. [Experimental study of intralymphatic chemotherapy in rabbits].
Satomi A; Takada Y; Ishida K
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2262-8. PubMed ID: 2955746
[TBL] [Abstract][Full Text] [Related]
10. Electron spin resonance detection of free radicals in the mercaptan-activation and UV-inactivation of neocarzinostatin.
Sheridan RP; Gupta RK
Biochem Biophys Res Commun; 1981 Mar; 99(1):213-20. PubMed ID: 6263270
[No Abstract] [Full Text] [Related]
11. NEOCARZINOSTATIN, AN ANTITUMOR ANTIBIOTIC OF HIGH MOLECULAR WEIGHT. ISOLATION, PHYSIOCHEMICAL PROPERTIES AND BIOLOGICAL ACTIVITIES.
ISHIDA N; MIYAZAKI K; KUMAGAI K; RIKIMARU M
J Antibiot (Tokyo); 1965 Mar; 18():68-76. PubMed ID: 14326086
[No Abstract] [Full Text] [Related]
12. On the conformation of Phe78 of a chromoprotein antibiotic, neocarzinostatin.
Imajo S; Ishiguro M; Tanaka T; Hirama M; Teplyakov A
Bioorg Med Chem; 1995 Apr; 3(4):429-36. PubMed ID: 8581426
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the stability of antitumor protein, neocarzinostatin. I. Stability of solution of neocarzinostatin (author's transl)].
Kono M; Haneda I; Koyama Y; Kikuchi M
Jpn J Antibiot; 1974 Dec; 27(6):707-14. PubMed ID: 4282494
[No Abstract] [Full Text] [Related]
14. Absorption, distribution and excretion of neocarzinostatin (NCS) in mice after oral administration.
Toriyama K; Fujita H; Ishida N
J Antibiot (Tokyo); 1975 Jan; 28(1):64-72. PubMed ID: 123896
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of neocarzinostatin, an antitumor protein.
Samy TS; Raso V
Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
[TBL] [Abstract][Full Text] [Related]
16. Role of epoxide in neocarzinostatin chromophore stability and action.
Lee SH; Goldberg IH
Mol Pharmacol; 1988 Apr; 33(4):396-401. PubMed ID: 2965788
[TBL] [Abstract][Full Text] [Related]
17. [Part I. Theory and computer simulation for cerebrospinal infusion].
Maeda H; Matsukado Y; Iwai Z; Uemura S; Kuratsu J; Takeshita J; Sano Y
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1040-5. PubMed ID: 6223592
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of the anticancer polypeptide neocarzinostatin.
Hall SW; Knight J; Broughton A; Benjamin RS; McKelvey E
Cancer Chemother Pharmacol; 1983; 10(3):200-4. PubMed ID: 6222845
[TBL] [Abstract][Full Text] [Related]
19. Pre-neocarzinostatin, a specific antagonist of neocarzinostatin.
Kikuchi M; Shoji M; Ishida N
J Antibiot (Tokyo); 1974 Oct; 27(10):766-74. PubMed ID: 4281770
[No Abstract] [Full Text] [Related]
20. [Neocarzinostatin: molecular mechanism of action and prospects for clinical use].
Köhnlein W; Jung G
Arzneimittelforschung; 1982; 32(11):1474-9. PubMed ID: 6217819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
